Bilateral Breast Cancer: Case Series
Bilateral Breast Cancer
DOI:
https://doi.org/10.60787/tnhj.v24i3.799Keywords:
Bilateral Breast Cancer, Case series, Port Harcourt, NigeriaAbstract
Background: Synchronous bilateral breast cancer is not so common a phenomenon, so also is the findings in the same patient, of different histologic types with differences in receptor status and or tumour grades. We are beginning to encounter this phenomenon in our centre, hence this series. This case-series reported observed bilateral breast cancer in patients seen at our centre in Nigeria over a 11-year period (from 2008 to 2019), to further enrich the literature on this phenomenon.
Case Presentation: Case 1 was a 44-year-old hypertensive diabetic who presented to the surgical out-patient clinic with bilateral breast mass and a history of right breast fall-off before presentation to hospital. Case 2 was a 48-year-old woman who presented as emergency with difficulty in breathing with two-year history of breast disease. Case 3, a 60-year-old businesswoman with bilateral breast disease of 4 years interval.
Conclusion: Late presentation, preference for alternative therapy and delay in commencement of conventional treatment of breast cancer, and consequent increase in morbidity are witnessed in this case series. This is occasioned by ignorance and inability to afford breast cancer care requiring action.
Downloads
References
Nisbet W. A Case of the Cure of Cancer of Both Breasts, the One Ulcerated, the Other Schirrous. The Medical and physical journal. 1800;4(20): 296-298.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DMJIjoc. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. 2010;127(12):2893-917.
Agbo S, Oboirien M, Gana GJIJ. Breast cancer incidence in Sokoto, Nigeria. 2013;2(2):1614-22.
Bernstein JL, Lapinski RH, Thakore SS, Doucette JT, Thompson WDJE. The descriptive epidemiology of second primary breast cancer. 2003;14(5):552-8.
Kurian AW, McClure LA, John EM, Horn-Ross PL, Ford JM, Clarke CAJJotNCI. Second primary breast cancer occurrence according to hormone receptor status. 2009;101(15):1058-65.
Huo D, Melkonian S, Rathouz PJ, Khramtsov A, Olopade OIJC. Concordance in histological and biological parameters between first and second primary breast cancers. 2011;117(5):907-15.
Gollamudi SV, Gelman RS, Peiro G, Schneider LJ, Schnitt SJ, Recht A, et al. Breast‐conserving therapy for stage I‐II synchronous bilateral breast carcinoma. 1997;79(7):1362-9.
Donovan AJJTSCoNA. Bilateral breast cancer. 1990;70(5):1141-9.
Intra M, Rotmensz N, Viale G, Mariani L, Bonanni B, Mastropasqua MG, et al. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution. 2004;101(5):905-12.
Al‐Jurf AS, Jochimsen PR, Urdaneta LF, Scott DHJJoso. Factors influencing survival in bilateral breast cancer. 1981;16(4):343-8.
Adami HO, Bergström R, Hansen JJC. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population‐based case‐control study. 1985;55(3):643-7.
de la Rochefordiere A, Asselain B, Scholl S, Campana F, Ucla L, Vilcoq JR, et al. Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. 1994;30(1):35-41.
Burns P, Dabbs K, May C, Lees A, Birkett L, Jenkins H, et al. Bilateral breast cancer in northern Alberta: risk factors and survival patterns. 1984;130(7):881.
Del Turco MR, Ciatto S, Perigli G, Borrelli D, Carcangiu ML, Santucci MJTJ. Bilateral cancer of the breast. 1982;68(2):155-60.
Chaudary M, Millis R, Hoskins E, Halder M, Bulbrook R, Cuzick J, et al. Bilateral primary breast cancer: a prospective study of disease incidence. 1984;71(9):711-4.
Fisher ER, Dignam J, Tan‐Chiu E, Costantino J, Fisher B, Paik S, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17: intraductal carcinoma. 1999;86(3):429-38.
Fisher ER, Anderson S, Redmond C, Fisher BJC. Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants. 1993;71(8):2507-14.
Mahfoudh W, Bouaouina N, Ahmed SB, Gabbouj S, Shan J, Mathew R, et al. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. 2012;39(2):1037-46.
Loman N, Johannsson O, Kristoffersson U, Olsson Hk, Borg AkJJotNCI. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. 2001;93(16):1215-23.
Abdulrahman GO, Rahman GAJJoce. Epidemiology of breast cancer in Europe and Africa. 2012;2012.
Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, et al. Estrogen receptor status in BRCA1-and BRCA2-related breast cancer: the influence of age, grade, and histological type. 2004;10(6):2029-34.
Anyanwu SJWAjom. Breast cancer in eastern Nigeria: a ten year review. 2000;19(2):120-5.
Victor J, Aligbe JJAjorh. Histopathological types of breast cancer in Nigerian women: a 12-year review (1993-2004). 2006;10(1):71-5.
Aghadiuno P, Akang E, Ladipo JJJotNMA. Simultaneous bilateral malignant breast neoplasms in Nigerian women. 1994;86(5):365.
Oguntola A, Aderonmu A, Adeoti M, Olatoke S, Akanbi O, Agodirin SJNPMJ. Male breast cancer in LAUTECH teaching hospital Osogbo, South Western Nigeria. 2009;16(2):166-70.
Nggada HA, Yawe KDT, Abdulazeez J, Khalil MAJTbj. Breast cancer burden in Maiduguri, North eastern Nigeria. 2008;14(3):284-6.
Olu-Eddo A, Momoh MJNqjohm. Clinicopathological study of male breast cancer in Nigerians and a review of the literature. 2010;20(3):121-4.
McCredie JA, Inch WR, Alderson MJC. Consecutive primary carcinomas of the breast. 1975;35(5):1472-7.
Anderson DE. Some characteristics of familial breast cancer. Cancer. 1971;28(6):1500-4.
Robbins GF, Berg JW. Bilateral primary breast cancers. A prospective clinicopathological study. Cancer. 1964;17(12):1501-27.
Slack N, Bross I, Nemoto T, Fisher B. Experiences with bilateral primary carcinoma of the breast. Surgery, gynecology & obstetrics. 1973;136(3):433.
Leis Jr HP. Managing the remaining breast. Cancer. 1980;46(S4):1026-30.
Del Turco MR, Ciatto S, Perigli G, Borrelli D, Carcangiu ML, Santucci M. Bilateral cancer of the breast. Tumori Journal. 1982;68(2):155-60.
Fisher ER, Fisher B, Sass R, Wickerham L. Pathologic findings from the national surgical adjuvant breast project (protocol no. 4): XI. Bilateral breast cancer. Cancer. 1984;54(12):3002-11.
Webber BL, Heise H, Neifeld JP, Costa J. Risk of subsequent contralateral breast carcinoma in a population of patients with in‐situ breast carcinoma. Cancer. 1981;47(12):2928-32.
McCredie JA, Inch WR, Alderson M. Consecutive primary carcinomas of the breast. Cancer. 1975;35(5):1472-7.
Al‐Jurf AS, Jochimsen PR, Urdaneta LF, Scott DH. Factors influencing survival in bilateral breast cancer. Journal of surgical oncology. 1981;16(4):343-8.
Khafagy MM, Schottenfeld D, Robbins GF. Prognosis of the second breast cancer. The role of previous exposure to the first primary. Cancer. 1975;35(3):596-9.
Bloom N, Daluvoy R, Ceccarelli F, Degenshein G. Bilateral mammary carcinoma; immunologic implications. New York state journal of medicine. 1980;80(6):908-10.
Senkus E, Szade J, Pieczyńska B, Żaczek A, Pikiel J, Sosińska-Mielcarek K, et al. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype. International journal of clinical and experimental pathology. 2014;7(1):353.
Senkus E, Szade J, Pieczyńska B, Kunc M, Pliszka A, Jassem J. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis focused on cell cycle regulation. Histology and histopathology. 2018;33(1):55-64.
Yadav S, Zakalik D. Abstract P5-08-14: Synchronous bilateral breast cancer compared to unilateral breast cancer: A population based study. AACR; 2017.
Chen S, Du C, Yang P, Zhang H, Kwan M, Zhang G. The molecular and clinicopathologic characteristics of bilateral breast cancer. Scientific reports. 2013;3:2590.
Purkayastha A, Sharma N, Lohia N. A rare case of triple negative synchronous bilateral invasive ductal carcinoma of breast. Archives of Medicine and Health Sciences. 2016;4(1):67.
Mertens WC, Hilbert V, Makari‐Judson G. Contralateral breast cancer: factors associated with stage and size at presentation. The breast journal. 2004;10(4):304-12.
Padmanabhan N, Subramanyan A, Radhakrishna S. Synchronous bilateral breast cancers. Journal of clinical and diagnostic research: JCDR. 2015;9(9):XC05.
Gong SJ, Rha SY, Jeung HC, Roh JK, Yang WI, Chung HC. Bilateral breast cancer: differential diagnosis using histological and biological parameters. Japanese journal of clinical oncology. 2007;37(7):487-92.
Renz DM, Böttcher J, Baltzer PA, Dietzel M, Vag T, Gajda M, et al. The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer. Breast cancer research and treatment. 2010;120(2):449-59.
Sanchez AG, Villanueva AG, Redondo C. Lobular carcinoma of the breast in a patient with Klinefelter's syndrome. A case with bilateral, synchronous, histologically different breast tumors. Cancer. 1986;57(6):1181-3.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Elenwo SN, Ijah RFOA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.